Health Trials

Advanced Liver Fibrosis

2

Review clinical trials related to Advanced Liver Fibrosis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Erlotinib for Hepatocellular Carcinoma Chemoprevention

This phase II randomized placebo-controlled trial studies low-dose erlotinib treatment to assess its efficacy and safety to prevent development of hepatocellular carcinoma in patients with advanced liver fibrosis or cirrhosis.

Participants needed: 60
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: University of Texas Southwestern Medical CenterUpdated: Jun 24, 2026Locations: 1
Eligibility criteria

Adults (≥ 18 years-old) [+7]

Prior treatment with epidermal growth factor receptor (EGFR) inhibitors [+3]

Read more
Status: Recruiting

SCREaning of Advanced Liver Fibrosis Using Non-Invasive Tests in General Population

The main objective of the study is to evaluate the pertinence of initiating screening for advanced hepatic fibrosis after a FIB4 result \> 2.67 automatically calculated in the local laboratory and followed by a specialized hepatic evaluation.

Participants needed: 502
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: University Hospital, AngersUpdated: Dec 8, 2025Locations: 6
Eligibility criteria

Age between 18 and 70 years [+4]

Ongoing specialized follow-up for a chronic liver disease [+6]

Read more